These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 2886638

  • 21. Modulation of acetylcholine release by cholecystokinin in striatum: receptor specificity; role of dopaminergic neuronal activity.
    Petkova-Kirova P, Giovannini MG, Kalfin R, Rakovska A.
    Brain Res Bull; 2012 Dec 01; 89(5-6):177-84. PubMed ID: 22981453
    [Abstract] [Full Text] [Related]

  • 22. The role of dopamine in regulation of thyrotropin-releasing hormone in the striatum and nucleus accumbens of the rat.
    Przegaliński E, Jaworska L, Konarska R, Gołembiowska K.
    Neuropeptides; 1991 Jul 01; 19(3):189-95. PubMed ID: 1680223
    [Abstract] [Full Text] [Related]

  • 23. Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    Compton DR, Johnson KM.
    J Pharmacol Exp Ther; 1989 Feb 01; 248(2):521-30. PubMed ID: 2918468
    [Abstract] [Full Text] [Related]

  • 24. Pharmacological and biochemical characterization of the D-1 dopamine receptor mediating acetylcholine release in rabbit retina.
    Hensler JG, Cotterell DJ, Dubocovich ML.
    J Pharmacol Exp Ther; 1987 Dec 01; 243(3):857-67. PubMed ID: 2961878
    [Abstract] [Full Text] [Related]

  • 25. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
    Schoffelmeer AN, De Vries TJ, Hogenboom F, Mulder AH.
    J Pharmacol Exp Ther; 1993 Oct 01; 267(1):205-10. PubMed ID: 8229747
    [Abstract] [Full Text] [Related]

  • 26. Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals.
    Maura G, Giardi A, Raiteri M.
    J Pharmacol Exp Ther; 1988 Nov 01; 247(2):680-4. PubMed ID: 2903237
    [Abstract] [Full Text] [Related]

  • 27. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices.
    Jin S, Johansson B, Fredholm BB.
    J Pharmacol Exp Ther; 1993 Nov 01; 267(2):801-8. PubMed ID: 7902434
    [Abstract] [Full Text] [Related]

  • 28. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE, Johnson KB, Mueller RA, Breese GR.
    J Pharmacol Exp Ther; 1993 May 01; 265(2):1001-10. PubMed ID: 8098756
    [Abstract] [Full Text] [Related]

  • 29. Modulation of dopaminergic terminal excitability by D1 selective agents: further characterization.
    Diana M, Young SJ, Groves PM.
    Neuroscience; 1991 May 01; 42(2):441-9. PubMed ID: 1680226
    [Abstract] [Full Text] [Related]

  • 30. Opposing effects of D-1 and D-2 receptor antagonists on acetylcholine levels in the rat striatum.
    Fage D, Scatton B.
    Eur J Pharmacol; 1986 Oct 07; 129(3):359-62. PubMed ID: 2877889
    [Abstract] [Full Text] [Related]

  • 31. Effect of neurotensin and immunneutralization with anti-neurotensin-serum on dopaminergic-cholinergic interaction in the striatum.
    Töröcsik A, Rakovska A, Görcs T, Vizi ES.
    Brain Res; 1993 May 28; 612(1-2):306-12. PubMed ID: 8101133
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Pharmacological characterization of dopamine receptors in the stellate ganglia with selective DA1 and DA2 receptor agonists and antagonists.
    Sabouni MH, Alkadhi KA, Lokhandwala MF.
    J Pharmacol Exp Ther; 1986 Jan 28; 236(1):65-70. PubMed ID: 2867216
    [Abstract] [Full Text] [Related]

  • 34. Functional antagonism of D-1 and D-2 dopaminergic mechanisms affecting striatal acetylcholine release.
    Gorell JM, Czarnecki B, Hubbell S.
    Life Sci; 1986 Jun 16; 38(24):2247-54. PubMed ID: 2940433
    [Abstract] [Full Text] [Related]

  • 35. Aspartate-releasing nerve terminals in rat striatum possess D-2 dopamine receptors mediating inhibition of release.
    Maura G, Carbone R, Raiteri M.
    J Pharmacol Exp Ther; 1989 Dec 16; 251(3):1142-6. PubMed ID: 2574740
    [Abstract] [Full Text] [Related]

  • 36. Release of acetylcholine and its dopaminergic control in slices from striatal grafts in the ibotenic acid-lesioned rat striatum.
    Wichmann T, Wictorin K, Björklund A, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec 16; 338(6):623-31. PubMed ID: 3149721
    [Abstract] [Full Text] [Related]

  • 37. Acetylcholine release in rat nucleus accumbens is regulated through dopamine D2-receptors.
    Wedzony K, Limberger N, Späth L, Wichmann T, Starke K.
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep 16; 338(3):250-5. PubMed ID: 3264055
    [Abstract] [Full Text] [Related]

  • 38. Pharmacologic evidence for direct dopaminergic regulation of striatal acetylcholine release.
    Gorell JM, Czarnecki B.
    Life Sci; 1986 Jun 16; 38(24):2239-46. PubMed ID: 2940432
    [Abstract] [Full Text] [Related]

  • 39. Striatal cholinergic function reflects differences in D-2 dopaminergic receptor activation.
    Forloni G, Bidzinski A, Fusi R, Ladinsky H, Consolo S.
    Life Sci; 1987 Oct 05; 41(14):1717-23. PubMed ID: 2958667
    [Abstract] [Full Text] [Related]

  • 40. Regional differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation in rat nucleus accumbens and neostriatum.
    Henselmans JM, Stoof JC.
    Brain Res; 1991 Dec 06; 566(1-2):1-7. PubMed ID: 1687661
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.